378 related articles for article (PubMed ID: 9494699)
1. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
[TBL] [Abstract][Full Text] [Related]
2. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man.
Mazza E; Ghigo E; Bellone J; Arvat E; Revelli E; Cella SG; Brambilla F; Müller EE; Camanni F
Endocrinol Exp; 1990 Mar; 24(1-2):211-9. PubMed ID: 1972919
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa.
Rolla M; Andreoni A; Belliti D; Ferdeghini M; Cristofani R; Müller EE
Endocrinol Exp; 1990 Mar; 24(1-2):195-204. PubMed ID: 2113857
[TBL] [Abstract][Full Text] [Related]
6. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
Gianotti L; Fassino S; Daga GA; Lanfranco F; De Bacco C; Ramunni J; Arvat E; MacCario M; Ghigo E
Clin Endocrinol (Oxf); 2000 Jun; 52(6):713-20. PubMed ID: 10848875
[TBL] [Abstract][Full Text] [Related]
7. An inhibition of the hypothalamic somatostatinergic tone is not the cause of the enhanced growth hormone response to growth hormone-releasing hormone in patients with liver cirrhosis.
Fanciulli G; Tomasi PA; Giusti M; Bertoncelli A; Deplano A; Garrucciu G; Delitala G
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):148-51. PubMed ID: 18095239
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
Pincelli AI; Rigamonti AE; Scacchi M; Cella SG; Cappa M; Cavagnini F; Müller EE
Eur J Endocrinol; 2003 Feb; 148(2):237-43. PubMed ID: 12590644
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus.
Martina V; Miola C; Maccario M; Talliano M; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1992 Nov; 24(11):520-3. PubMed ID: 1333441
[TBL] [Abstract][Full Text] [Related]
10. Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.
Mancini A; Bianchi A; Tacchino RM; Perrelli M; Milardi D; Gentilella R; Giampietro A; Fusco A; Valle D; De Marinis L
Metabolism; 2001 Apr; 50(4):382-6. PubMed ID: 11288030
[TBL] [Abstract][Full Text] [Related]
11. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
12. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
13. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
Tamai H; Komaki G; Matsubayashi S; Kobayashi N; Mori K; Nakagawa T; Truong MP; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
[TBL] [Abstract][Full Text] [Related]
14. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
[TBL] [Abstract][Full Text] [Related]
15. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man.
Arvat E; Gianotti L; Ramunni J; DiVito L; Deghenghi R; Camanni F; Ghigo E
J Endocrinol Invest; 1996 Jan; 19(1):25-9. PubMed ID: 8851688
[TBL] [Abstract][Full Text] [Related]
16. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M
Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349
[TBL] [Abstract][Full Text] [Related]
18. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
Valcavi R; Zini M
Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
[TBL] [Abstract][Full Text] [Related]
19. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
